Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01477879
Other study ID # HSV1&2
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received November 15, 2011
Last updated November 19, 2011
Start date January 2011
Est. completion date March 2011

Study information

Verified date November 2011
Source Naturopaths International
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.


Description:

Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for evaluation. Up to 50 patients may be enrolled.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date March 2011
Est. primary completion date March 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Hsv 1&2

Exclusion Criteria:

- No active lesions

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Versabase gel with sarracenia purpurea 20% liquid extract
Topical application of gel/plant mix to lesions
placebo (versabase gel only)
versabase gel only

Locations

Country Name City State
United States Naturopaths international Flagstaff Arizona

Sponsors (1)

Lead Sponsor Collaborator
Naturopaths International

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Pain scale-- subjective 2 weeks No
Primary Size Measure lesion size over 2 weeks 2 weeks No
Secondary Appearance Photo taken of lesion w patient informed consent 2 weeks No
See also
  Status Clinical Trial Phase
Completed NCT04664127 - Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
Completed NCT01321502 - Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions N/A
Completed NCT01321515 - Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions N/A
Completed NCT02092233 - A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients N/A
Completed NCT00362596 - A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand Phase 4